NPI registry status
Active
2026 NPPES data Dermatology Physician NPI 1417955436 MD
Verify on CMS → Marti Rothe, MD
Dermatology Physician in Farmington, Connecticut.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 15,011 in Dermatology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 567 beneficiaries · Dermatology Physician avg: 799
Generic prescribing
78%
generic claims · 22% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
79.3/100
▼ 4 pts below national avg 83.5 · Above neutral
Industry payments
$57.73
2 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Marti Rothe, MD reported a CMS MIPS final score of 79.3/100 - below the 83.5 national average - and filed 1,850 Medicare Part D claims in 2024.
- 79.3/100
- MIPS score · -4 vs avg
- 2K
- Part D claims, 2024
- 78%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Marti Rothe, MD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1417955436), first enumerated 07/13/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 1,850 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 79.3/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$57.73 in reported industry payments (2 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1417955436 · Dermatology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-BELOW · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1417955436
- ENUM-LEGACY 2005
- TAX-MID 15K Dermatology Physician
- MIPS-BELOW 79.3/100
- RX-MID 1,850
- BOOK-THIN 241 in Connecticut
- PHOTO-FINISH Thomas Hagele · ±0.1
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Rothe · this pro…
Rothe · this provider
79.3 MIPS pts
- Alice Do, DO · h…
Alice Do, DO
79.4 MIPS pts
- Thomas Hagele · …
Thomas Hagele
79.4 MIPS pts
- Laura Schaeffer,…
Laura Schaeffer, DO
79.4 MIPS pts
- Bethany Wyles · …
Bethany Wyles
79.4 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Marti Rothe, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
79 ≥ 26th percentile 26% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Marti Rothe, MD sits
This provider among dermatology physician peers
Across the 5,700 dermatology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Marti Rothe, MD writes more Part D claims than 92% of them and scores higher on MIPS quality than 28% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one dermatology physician peer from a representative sample of 60; the gold marker is Marti Rothe, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Marti Rothe, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Marti Rothe, MD?
Near national averagePrimary specialty
Dermatology Physician
Medicare Part D claims
1,850 132% vs specialty avg
MIPS final score
79.3/100 4.2 pts vs avg
Specialty distribution in Connecticut
How Dermatology Physician compares to other specialties among Connecticut providers
Medicare quality performance, MIPS
Marti Rothe, MD's 2023 MIPS final score plotted against the Dermatology Physician national average
- MIPS Final Score
- 79.3/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1417955436 |
|---|---|
| Specialty | Dermatology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 07/13/2005 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
79.3496
Final Score
Measured-score avg: 83.5
69.2231
Quality
48.0871
Cost
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Marti Rothe, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
University OF Connecticut Health Center
Farmington, CT
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Marti Rothe, MD. Source: openpaymentsdata.cms.gov.
Total received
$58
Largest payer
GENZYME CORPORATION
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
Marti Rothe, MD - brand share 22.0%
Dermatology Physician average
22% brand-name claims vs 78% generic, on 1,850 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
1,850
Total Claims
$4.2M
Total Drug Cost
567
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 2,391.7
- Total Day Supply
- 64,155
- Brand vs Generic
- 22% brand / 78% generic
- Brand Drug Cost
- $4.2M
- Generic Drug Cost
- $68K
- Antibiotic Claims
- 40
Patient Demographics
- Average Patient Age
- 75.0 years
- Avg HCC Risk Score
- 1.11
- Gender Split
- 62% female / 38% male
- Age Distribution
- <65: 42, 65-74: 227, 75-84: 216, 85+: 82
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Marti Rothe, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Ketoconazole
Ketoconazole
464 claims
- Clobetasol Propion… 135
Clobetasol Propionate
135 claims
- Triamcinolone Acet… 105
Triamcinolone Acetonide
105 claims
- Skyrizi Pen 63
Skyrizi Pen
63 claims
- Metronidazole 62
Metronidazole
62 claims
- Fluorouracil 53
Fluorouracil
53 claims
- Nystatin 45
Nystatin
45 claims
- Doxycycline Hyclate 41
Doxycycline Hyclate
41 claims
| Drug | Claims |
|---|---|
| Ketoconazole | 464 |
| Clobetasol Propionate | 135 |
| Triamcinolone Acetonide | 105 |
| Skyrizi Pen Risankizumab-Rzaa | 63 |
| Metronidazole | 62 |
| Fluorouracil | 53 |
| Nystatin | 45 |
| Doxycycline Hyclate | 41 |
| Stelara Ustekinumab | 39 |
| Tacrolimus | 36 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Dermatology Physician Overview
How Marti Rothe, MD fits within the Dermatology Physician landscape nationally.
15,011
Dermatology Physician Providers in US
53
States with Dermatology Physician
799
Avg Claims per Provider
Marti Rothe, MD's 1,850 claims are above the specialty average of 799.
Nationwide Dermatology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Rothe, both outside Connecticut so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (79.3 here).
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Dermatology Physician Providers in Connecticut
Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as Rothe.
One of 241 Dermatology Physician providers enrolled in Connecticut, 5 are shown here.
Dr. Donna Aiudi
M.D.
Farmington, CT
Dr. Michael Albert
M.D.
Newington, CT
Dr. Jeffrey Alter
MD
Waterbury, CT
Dr. Richard Antaya
MD
New Haven, CT
Dr. Nina Antonov
M.D.
Westport, CT
Compare Dermatology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Marti Rothe, MD's specialty? ▼
Marti Rothe, MD specializes in Dermatology Physician and practices in Farmington, Connecticut. Credentials: MD.
How much does Marti Rothe, MD prescribe under Medicare Part D? ▼
In 2024, Marti Rothe, MD wrote 1,850 Medicare Part D claims totaling $4.2M in drug costs for 567 beneficiaries.
What is Marti Rothe, MD's Medicare quality score? ▼
Marti Rothe, MD has a CMS MIPS Final Score of 79.3/100 (Quality: 69.2, Cost: 48.1). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Marti Rothe, MD located? ▼
Marti Rothe, MD is located at 263 FARMINGTON AVE, Farmington, CT, 06030. Phone: (860) 679-4600.
What is Marti Rothe, MD's NPI number? ▼
Marti Rothe, MD's National Provider Identifier (NPI) is 1417955436, issued on 07/13/2005.
Does Marti Rothe, MD prescribe more brand-name or generic drugs? ▼
Marti Rothe, MD's prescribing is 22% brand-name and 78% generic drugs by claim count, with $4.2M in brand drug costs.
How many Dermatology Physician providers are there in the US? ▼
There are 15,011 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 799 Medicare Part D claims per year.
What drugs does Marti Rothe, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Marti Rothe, MD's most frequently prescribed drugs include Ketoconazole, Clobetasol Propionate, Triamcinolone Acetonide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Marti Rothe, MD accept Medicare? ▼
Marti Rothe, MD appears in CMS Medicare data with 1,850 Part D claims and 567 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Marti Rothe, MD's credentials? ▼
Marti Rothe, MD's NPI is 1417955436 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.